BMJ Open (Mar 2022)
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo
- ,
- Deborah Watson-Jones,
- Shelley Lees,
- Brian Greenwood,
- Daniel G Bausch,
- Peter G Smith,
- Chrissy H Roberts,
- Nathalie Imbault,
- Anton Camacho,
- W John Edmunds,
- Eric Delaporte,
- Melanie Saville,
- John Johnson,
- Ira M Longini,
- Hugo Kavunga-Membo,
- Rebecca F Grais,
- Steve Ahuka,
- Natalie Roberts,
- Edward M Choi,
- Tansy Edwards,
- Maarten Leyssen,
- Bart Spiessens,
- Kerstin Luhn,
- Macaya Douoguih,
- Richard Hatchett,
- Jean-Jacques Muyembe,
- W John Edmunds,
- Daniela Manno,
- Rebecca Grais,
- Susan Rattigan,
- Grace Mambula,
- Patient Mumbere Kighoma,
- Marie Burton,
- Gerald Voss
Affiliations
- Deborah Watson-Jones
- 1 Mwanza Intervention Trials Unit, Mwanza, Tanzania
- Shelley Lees
- Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK
- Brian Greenwood
- Department of Disease Control, London School of Hygiene and Tropical Medicine, Faculty of Infectious and Tropical Diseases, London, UK
- Daniel G Bausch
- UK Public Health Rapid Support Team, London School of Hygiene & Tropical Medicine/Public Health England, London, UK
- Peter G Smith
- MRC International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK
- Chrissy H Roberts
- Clinical Research, London School of Hygiene & Tropical Medicine, London, UK
- Nathalie Imbault
- CEPI, Oslo, Norway
- Anton Camacho
- Epicentre, Paris, Île-de-France, France
- W John Edmunds
- Modelling & Economics Unit, Health Protection Agency, 61 Colindale Avenue, Colindale, London NW9 5EQ, UK
- Eric Delaporte
- Laboratoire Rétrovirus, Institut de Recherche pour le Développement (IRD) Montpellier, France and University of Montpellier
- Melanie Saville
- Enteric and Respiratory Virus Laboratory, CPHL, London, UK
- John Johnson
- Ira M Longini
- professor
- Hugo Kavunga-Membo
- L’Institut National de Recherche Biomédicale, Goma, Democratic Republic of the Congo
- Rebecca F Grais
- Epicentre, Paris, Île-de-France, France
- Steve Ahuka
- L’Institut National de Recherche Biomédicale, Goma, Democratic Republic of the Congo
- Natalie Roberts
- MSF, Paris, France
- Edward M Choi
- London School of Hygiene & Tropical Medicine, London, UK
- Tansy Edwards
- London School of Hygiene & Tropical Medicine, London, UK
- Maarten Leyssen
- Janssen Vaccines and Prevention BV, Leiden, Zuid-Holland, The Netherlands
- Bart Spiessens
- Janssen Vaccines and Prevention BV, Leiden, Zuid-Holland, The Netherlands
- Kerstin Luhn
- Janssen Vaccines and Prevention BV, Leiden, Zuid-Holland, The Netherlands
- Macaya Douoguih
- Janssen Vaccines and Prevention BV, Leiden, Zuid-Holland, The Netherlands
- Richard Hatchett
- Coalition for Epidemic Preparedness Innovations, Oslo, Norway
- Jean-Jacques Muyembe
- L’Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo
- W John Edmunds
- Daniela Manno
- Rebecca Grais
- Susan Rattigan
- Grace Mambula
- Patient Mumbere Kighoma
- Marie Burton
- Gerald Voss
- DOI
- https://doi.org/10.1136/bmjopen-2021-055596
- Journal volume & issue
-
Vol. 12,
no. 3
Abstract
No abstracts available.